NEXTDC Ltd
F:2NX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NEXTDC Ltd
F:2NX
|
AU |
|
Oncternal Therapeutics Inc
F:GTU2
|
US |
|
C
|
Collplant Biotechnologies Ltd
F:CPT
|
IL |
|
MacDonald Mines Exploration Ltd
F:3M7
|
CA |
|
K
|
Knight Therapeutics Inc
F:04K
|
CA |
Wall St Price Targets
2NX Price Targets Summary
NEXTDC Ltd
According to Wall Street analysts, the average 1-year price target for 2NX is 13.74 EUR with a low forecast of 10.28 EUR and a high forecast of 22.26 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2NX's stock price target?
Price Target
13.74
EUR
According to Wall Street analysts, the average 1-year price target for 2NX is 13.74 EUR with a low forecast of 10.28 EUR and a high forecast of 22.26 EUR.
What is the Revenue forecast for NEXTDC Ltd?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Revenue has been 42%. The projected CAGR for the next 7 years is 26%.
What is the Gross Profit forecast for NEXTDC Ltd?
Projected CAGR
28%
The compound annual growth rate for Gross Profit over the next 5 years is 28%.
What is the Operating Income forecast for NEXTDC Ltd?
Projected CAGR
44%
The compound annual growth rate for Operating Income over the next 3 years is 44%.
